Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study.

Autor:	Umeda, Yoshiyasu1,2 (AUTHOR), Yoshikawa, Shusuke3 (AUTHOR), Kiniwa, Yukiko4 (AUTHOR), Maekawa, Takeo5 (AUTHOR), Yamasaki, Osamu6 (AUTHOR), Isei, Taiki7 (AUTHOR), Matsushita, Shigeto8 (AUTHOR), Nomura, Motoo9 (AUTHOR), Nakai, Yasuo10 (AUTHOR), Fukushima, Satoshi11 (AUTHOR), Saito, Shintaro12 (AUTHOR), Takenouchi, Tatsuya13 (AUTHOR), Tanaka, Ryo2 (AUTHOR), Kato, Hiroshi14 (AUTHOR), Otsuka, Atsushi15 (AUTHOR), Matsuya, Taisuke16 (AUTHOR), Baba, Natsuki17 (AUTHOR), Nagase, Kotaro18 (AUTHOR), Inozume, Takashi19 (AUTHOR), Onuma, Takehiro20 (AUTHOR)
Zdroj:	European Journal of Cancer. Nov2021, Vol. 157, p361-372. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect